Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits

References

• Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A,  Lake AJ,  Wilson R,  Sherman RL, et al. 2017. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst.109:djx030. doi: 10.1093/jnci/djx030.
   Google Scholar
• Wörns MA, Galle PR. 2014. HCC therapies—lessons learned. Nat Rev Gastroenterol Hepatol. 11:447–452. doi:10.1038/nrgastro.2014.10.
   PubMed Web of Science ®Google Scholar
• Lencioni R, De BT, Soulen MC, Rilling WS, Geschwind JF. 2016. Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data. Hepatology. 64:106–116. doi:10.1002/hep.28453.
   PubMed Web of Science ®Google Scholar
• El-Serag HB. 2011. Current concepts hepatocellular carcinoma. N Engl J Med. 365:1118–1127. doi:10.1056/NEJMra1001683.
   PubMed Web of Science ®Google Scholar
• Bo Z, Wang J, Yan Z. Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model. Onco Targets Ther. 2014;7:1945.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol. 2001;35:421–430.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, et al. 2002. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 359:1734–1739. doi:10.1016/S0140-6736(02)08649-X.
   PubMed Web of Science ®Google Scholar
• Feng D, Zhang X, Shen W, Chen J, Liu L, Gao G. Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors. Onco Targets Ther. 2015;8:2601–2611.
   PubMed Web of Science ®Google Scholar
• Davda S, Bezabeh T. 2006. Advances in methods for assessing tumor hypoxia in vivo: implications for treatment planning. Cancer Metastasis Rev. 25:469. doi:10.1007/s10555-006-9009-z.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Mayer A. 2007. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26:225–239. doi:10.1007/s10555-007-9055-1.
   PubMed Web of Science ®Google Scholar
• Strebel BM, Dufour JF. 2008. Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease. Expert Rev Anticancer Ther. 8:1743–1749. doi:10.1586/14737140.8.11.1743.
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;8:S62–S7.
   PubMed Web of Science ®Google Scholar
• Virmani S, Rhee TK, Ryu RK, Sato KT, Lewandowski RJ, Mulcahy MF, Kulik LM, Szolc-Kowalska B, Woloschak GE, Yang G-Y, et al. 2008. Comparison of hypoxia-inducible factor-1 alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. J Vasc Interv Radiol. 19:1483–1489. doi:10.1016/j.jvir.2008.06.017.
   PubMed Web of Science ®Google Scholar
• Liang B, Zheng CS, Feng GS, Wu HP, Wang Y, Zhao H, Qian J, Liang H-M. 2010. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model. Cardiovasc Intervent Radiol. 33:806–812. doi:10.1007/s00270-009-9762-9.
   PubMed Web of Science ®Google Scholar
• Devassy JG, Nwachukwu ID, Jones PJ. 2015. Curcumin and cancer: barriers to obtaining a health claim. Nutr Rev. 73:155–165. doi:10.1093/nutrit/nuu064.
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee J, Huh TL, Lee YS. 2013. Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53. Mol Cells. 35:526. doi:10.1007/s10059-013-0038-5.
   PubMed Web of Science ®Google Scholar
• Ranjan AP, Mukerjee A, Helson L, Gupta R, Vishwanatha JK. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis. Anticancer Res. 2013;33:3603–3609.
   PubMed Web of Science ®Google Scholar
• Bae MK, Kim SH, Jeong JW, Lee YM, Kim HS, Kim SR, Yun I, Bae SK, Kim KW. 2006. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol Rep. 15:1557–1562.
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee J, Lee YS. 2013. Curcumin in various cancers. Biofactors. 39:56–68. doi:10.1002/biof.1068.
   PubMed Web of Science ®Google Scholar
• Jalili S, Saeedi M. 2016. Study of curcumin behavior in two different lipid bilayer models of liposomal curcumin using molecular dynamics simulation. J Biomol Struct Dyn. 34:327. doi:10.1080/07391102.2015.1030692.
   PubMed Web of Science ®Google Scholar
• Zhou S, Li J, Xu H, Zhang S, Chen X, Chen W, Yang S, Zhong S, Zhao J, Tang J. 2017. Liposomal curcumin alters chemosensitivity of breast cancer cells to adriamycin via regulating microRNA expression. Gene. 622:1–12. doi:10.1016/j.gene.2017.04.026.
   PubMed Web of Science ®Google Scholar
• Li Q, Du J, Yu M, He G, Luo W, Li H, Zhou X. 2009. Transmission electron microscopy of VX2 liver tumors after high-intensity focused ultrasound ablation enhanced with SonoVue. Adv Ther. 26:117–125. doi:10.1007/s12325-008-0126-7.
   PubMed Web of Science ®Google Scholar
• Zhao X, Town JR, Li F, Zhang X, Cockcroft DW, Gordon JR. 2009. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol. 182:3213. doi:10.4049/jimmunol.0800551.
   PubMed Web of Science ®Google Scholar
• Hasan M, Belhaj N, Benachour H, Barberi-Heyob M, Kahn CJF, Jabbari E, Linder M, Arab-Tehrany E. 2014. Liposome encapsulation of curcumin: physico-chemical characterizations and effects on MCF7 cancer cell proliferation. Int J Pharm. 461:519–528. doi:10.1016/j.ijpharm.2013.12.007.
   PubMed Web of Science ®Google Scholar
• Valapala M, Thamake SI, Vishwanatha JK. 2011. A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. J Cell Sci. 124:1453. doi:10.1242/jcs.069567.
   PubMed Web of Science ®Google Scholar
• Li L, Ahmed B, Mehta K, Kurzrock R. 2007. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther. 6:1276–1282. doi:10.1158/1535-7163.MCT-06-0556.
   PubMed Web of Science ®Google Scholar
• Calvagno MG, Celia C, Paolino D, Cosco D, Iannone M, Castelli F, Doldo P, Frest M. 2007. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. Curr Drug Deliv. 4: 89–101.
   Google Scholar
• Wang WZ, Li L, Liu MY, Jin XB, Mao JW, Pu QH, Meng M-J, Chen X-G, Zhu J-Y. 2013. Curcumin induces FasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells. Life Sci. 92:352–358. doi:10.1016/j.lfs.2013.01.013.
   PubMed Web of Science ®Google Scholar
• Anastasiadis AG, Bemis DL, Stisser BC, Salomon L, Ghafar MA, Buttyan R. Tumor cell hypoxia and the hypoxia-response signaling system as a target for prostate cancer therapy. Curr Drug Targets. 2003;4. doi:10.2174/1389450033491136.
   PubMed Web of Science ®Google Scholar
• Kizakakondoh S, Inoue M, Harada H, Hiraoka M. 2003. Tumor hypoxia: a target for selective cancer therapy. Cancer Sci. 94:1021. doi:10.1111/j.1349-7006.2003.tb01395.x.
   PubMed Web of Science ®Google Scholar
• Ghattass K, Assah R, Elsabban M, Galimuhtasib H. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy. Curr Cancer Drug Targets. 2013;13. doi:10.2174/15680096113139990004.
   PubMed Web of Science ®Google Scholar
• Liao D, Johnson RS. 2007. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 26:281–290. doi:10.1007/s10555-007-9066-y.
   PubMed Web of Science ®Google Scholar
• Nagaraju GP, Bramhachari PV, Raghu G, El-Rayes BF. 2015. Hypoxia inducible factor-1α: its role in colorectal carcinogenesis and metastasis. Cancer Lett. 366:11. doi:10.1016/j.canlet.2015.06.005.
   PubMed Web of Science ®Google Scholar
• Duan W, Chang Y, Li R, Xu Q, Lei J, Yin C, Li T, Wu Y, Ma Q, Li X. 2014. Curcumin inhibits hypoxia inducible factor‑1α‑induced epithelial‑mesenchymal transition in HepG2 hepatocellular carcinoma cells. Mol Med Rep. 10:2505–2510. doi:10.3892/mmr.2014.2551.
   PubMed Web of Science ®Google Scholar
• Mizuno T, Nagao M, Yamada Y, Narikiyo M, Ueno M, Miyagishi M, Taira K, Nakajima Y. 2006. Small interfering RNA expression vector targeting hypoxia-inducible factor 1 alpha inhibits tumor growth in hepatobiliary and pancreatic cancers. Cancer Gene Ther. 13:131–140. doi:10.1038/sj.cgt.7700871.
   PubMed Web of Science ®Google Scholar
• Waligã3Rska-Stachura J, Jankowska A, Waśko R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-Błaszyk D, Shimek V, Ruchała M. Survivin–prognostic tumor biomarker in human neoplasms–review. Ginekol Pol. 2012;83:537–540.
   PubMed Web of Science ®Google Scholar
• Dit Ruys SP, Delaive E, Demazy C, Dieu M, Raes M, Michiels C. 2009. Identification of DH IC-2 as a HIF-1 independent protein involved in the adaptive response to hypoxia in tumor cells: A putative role in metastasis. Biochim Biophys Acta. 1793:1676–1690. doi:10.1016/j.bbamcr.2009.09.003.
   PubMed Web of Science ®Google Scholar
• Rhee TK, Young JY, Larson AC. 2007. Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1α in rabbit VX2 liver tumors. J Vasc Interv Radiol. 18:639. doi:10.1016/j.jvir.2007.02.031.
   PubMed Web of Science ®Google Scholar
• Chen C, Wang J, Liu R, Qian S. 2012. RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors. Tumour Biol. 33:1095–1103. doi:10.1007/s13277-012-0349-8.
   PubMedGoogle Scholar
• Pang R, Poon RTP. 2006. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett. 242:151–167. doi:10.1016/j.canlet.2006.01.008.
   PubMed Web of Science ®Google Scholar
• Mondal G, Barui S, Saha S, Chaudhuri A. 2013. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature. J Control Release. 172:832–840. doi:10.1016/j.jconrel.2013.08.302.
   PubMed Web of Science ®Google Scholar
• Xu MX, Zhao L, Deng C, Yang L, Wang Y, Guo T, Li L, Lin J, Zhang L. 2013. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway. Int J Oncol. 43:1951–1959. doi:10.3892/ijo.2013.2107.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhou X, He X, Dai M, Zhang Q. Curcumin induces apoptosis involving bax/bcl-2 in human hepatoma SMMC-7721 cells. Asian Pac J Cancer Prev. 2011;12:1925–1929.
   PubMedGoogle Scholar
• Cmielová J, Rezáčová M. 2011. p21Cip1/Waf1 protein and its function based on a subcellular localization [corrected]. J Cell Biochem. 112:3502–3506. doi:10.1002/jcb.23296.
   PubMed Web of Science ®Google Scholar
• Ju Z, Choudhury AR, Rudolph KL. 2007. A dual role of p21 in stem cell aging. Ann N Y Acad Sci. 1100:333. doi:10.1196/annals.1395.030.
   PubMed Web of Science ®Google Scholar
• Savio M. 2010. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res Rev Mutat Res. 704:12–20. doi:10.1016/j.mrrev.2010.01.009.
   Web of Science ®Google Scholar
• Warfel NA, Eldeiry WS. 2013. p21WAF1 and tumourigenesis: 20 years after. Curr Opin Oncol. 25:52–58. doi:10.1097/CCO.0b013e32835b639e.
   PubMed Web of Science ®Google Scholar
• Elham M, Shaahin H. 2014. Sohlh2 inhibits ovarian cancer cell proliferation by the upregulation of p21 and downregulation of cyclin D1. Carcinogenesis. 35:1863–1871. doi:10.1093/carcin/bgu113.
   PubMed Web of Science ®Google Scholar
• Cardin R. 2008. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol. 103:914–921. doi:10.1111/j.1572-0241.2007.01712.x.
   PubMed Web of Science ®Google Scholar